Doing Business In Quebec

October 27, 2017

Download our complete guide to develop your business in Quebec

Back to the publications list

Stay abreast of breaking legal news

M’abonner

May 6, 2026

Eight partners recognized as leaders in Canada for their expertise in infrastructure, according to Lexpert

On May 6, 2026, Lexpert recognized the expertise of five of our partners in its 2026 Lexpert Special Edition:Infrastructure. Laurence Bich-Carrière, Jean-Sébastien Desroches, Christian Dumoulin, Nicolas Gagnon, Édith Jacques, Marc-André Landry, Ouassim Tadlaoui and André Vautour now rank among Canada’s leaders in supporting economic players in the infrastructure industry. Laurence Bich-Carrière, is a member of the Quebec and Ontario Bar Associations, Laurence Bich-Carrière practices within the Litigation and Dispute Resolution group, in a versatile civil and commercial litigation practice specializing in complex litigation (class actions, appeals, extraordinary remedies, private international law). Jean-Sébastien Desroches practises business law and focuses primarily on mergers and acquisitions, infrastructure, renewable energy and project development as well as strategic partnerships. He has had the opportunity to steer several major transactions—complex legal operations, cross-border transactions, reorganizations, and investments—in Canada and at an international level on behalf of Canadian, American, and European clients and international corporations and institutional clients in the manufacturing, transportation, pharmaceutical, financial, and renewable energy sectors. Christian Dumoulin is a partner in the firm’s Business Law Group. He served as Managing Partner of the Sherbrooke office from 2015 to 2023 and sat on the firm’s Board of Directors from 2015 to 2017, and again in 2024. He specializes in mergers and acquisitions, commercial law and real estate law, and acts as a business and strategic advisor to clients of all sizes. Recognized for his rigour and practical approach, he supports clients in complex transactions (reorganizations, financings, sales and acquisitions, shareholder disputes). He has also been advising on infrastructure projects for more than fifteen years, including public-private partnerships, as well as on all aspects of commercial real estate law. Nicolas Gagnon focuses his practice on construction law and suretyship. He counsels contractors, public and private sector clients, professional services firms as well as surety companies at every stage of construction projects. He advises clients on the public bidding and procurement processes and participates in the negotiation and drafting of contractual documents involving various project delivery methods, such as public-private partnership projects and design, construction, financing and maintenance contracts. In addition to advising various construction industry stakeholders on construction management and any claims that may arise, he also assists them with dispute resolution processes. Édith Jacques is a partner in the Business Law Group in Montréal. She specializes in mergers and acquisitions and commercial and international law. Édith acts as strategic business advisor for medium to large private companies. Marc-André Landry is a member of the Litigation and Conflict Resolution group and focuses his practice on commercial litigation. He frequently assists his clients in resolving their disputes through negotiation, mediation or arbitration, or before the various courts of law. Over the years, he has represented businesses in many sectors, including construction, real estate, renewable energy, conventional energy, new technologies, financial services and pharmaceuticals. Ouassim Tadlaoui is a partner in the firm’s Litigation and Dispute Resolution Group and focuses his practice on banking litigation, restructuring, bankruptcy and insolvency, as well as construction surety. He represents chartered banks and other financial institutions and alternative lenders as creditors, as well as certain debtors, in bankruptcy and restructuring proceedings. He also represents and advises surety companies, as well as national and international businesses, in insolvency, bankruptcy and restructuring matters in the construction industry. André Vautour practises corporate law and commercial law, and is specifically interested in corporate governance, strategic alliances, joint ventures, investment funds, and mergers and acquisitions of private companies. He also practises technology law (drafting technology development and transfer agreements, licensing agreements, distribution agreements, outsourcing agreements, and e-commerce agreements). About Lavery Lavery is the leading independent law firm in Quebec. Its more than 200 professionals, based in Montréal, Québec City, Sherbrooke and Trois-Rivières, work every day to offer a full range of legal services to organizations doing business in Quebec. Recognized by the most prestigious legal directories, Lavery professionals are at the heart of what is happening in the business world and are actively involved in their communities. The firm’s expertise is frequently sought after by numerous national and international partners to provide support in cases under Quebec jurisdiction.

Read more

Publications that might interest you

June 10, 2026

The Legal Pitfalls of Using Human DNA and Tissue in Quebec-based Biotechnology Projects

Biotechnology projects rely on sensitive genetic data and biological material Nowadays, innovation-driven companies involved in life sciences, research and biotechnology handle some of the most legally sensitive assets: human tissue, biological material and genetic data. Innovation models involving tissue engineering, biobanks or AI-based analytical technologies are now based on the transfer and use of biological data with high scientific and commercial value. Yet, many organizations still prioritize the scientific and operational aspects of their projects without giving sufficient consideration to the legal restrictions that arise when a project involves a person’s DNA or biological material. From a business standpoint, the risk is that an organization—whether a private company or a public institution—might develop a technology, but then be unable to market that technology because it does not hold the necessary rights to use the biological material and information involved. In Canada, and particularly in Quebec, laws that protect personal and health information have become central to such projects.1 We are no longer simply dealing with typical cybersecurity or privacy concerns. These laws directly affect how biological material is: collected used transferred stored altered and potentially leveraged for commercial or collaborative research purposes2. Why DNA and human tissue are subject to a particular legal protection The highly sensitive nature of DNA and genetic data is no longer disputed. Canadian case law has long recognized the highly personal and private nature of this type of information.3 It also emphasizes the fact that human tissue and genetic data play a unique role in research and innovation projects because of the identification risks they carry, their scientific value, and the ethical and commercial concerns related to their use.4 This perspective is evident in section 2 of the Act respecting health and social services information5, for example, which defines health information as any information that concerns “any material taken from [a] person,” including biological material. Section 5 and following of this act set out the conditions under which such information may be used, disclosed or transferred in the context of research or collaboration involving third parties6 These obligations supplement those set forth in the Act respecting the protection of personal information in the private sector,7 which requires in particular that personal information be collected for specific and legitimate purposes, and that it be used in a manner consistent with the purposes for which it was originally collected.8 Artificial intelligence, genetic data and the risk of re-identification From a biotechnology perspective, the matter becomes particularly touchy when human tissue or genetic data, which was initially collected for clinical or scientific purposes, is then used for technology or artificial intelligence projects. In fact, many projects that utilize artificial intelligence require not only biological samples and DNA, but also phenotypic data, health information and family history information from the patients from whom the biological samples were obtained. As such, there is a real risk of data cross-referencing here that must be managed with full awareness of the potential impact on those individuals. In certain projects, combining DNA with family information could compromise the privacy of not only the individuals from whom the biological material was collected, but also their family members. This problem has already been raised in relation to genetic genealogy.9 Consent, health information and secondary uses tend to be overlooked A project that was initially intended for research purposes can quickly drift into secondary uses that extend beyond its original scope. However, consent obtained at the outset does not necessarily cover all future uses, particularly where derived data or analysis results are integrated into technology platforms or used to develop analytical tools.10 Research agreements and biological material transfer agreements constitute an essential governance mechanism Agreements have thus become the key governance mechanism. Biological material transfer agreements, collaborative research agreements and data-related provisions are no longer solely intended to protect intellectual property or commercial confidentiality. They also serve to define the processes involved in transferring biological samples, ensuring data traceability, imposing restrictions on reuse and meeting anonymization requirements.11 The rights relating to intellectual property, DNA and personal information are interconnected The interplay between biotech innovation, intellectual property and personal information protection raises complex legal issues. A genetic database or a biological model derived from it can be both a strategic business asset AND a collection of highly sensitive personal information. However, any intellectual property rights that may apply to the results, algorithms or analytical methods do not exempt organizations from the obligations set out in Quebec laws regarding the protection of personal and health information12. On the contrary, in order to market a technology, organizations must hold not only the necessary intellectual property rights but also the rights required under the legal framework governing health and personal information. The commercialization of a technology begins long before it is brought to market As organizations increasingly seek to leverage data from scientific research, issues related to the governance of human tissue, DNA and biological material should no longer be treated as a secondary consideration addressed only at the end of a project. They are becoming an integral part of the legal, operational and commercial framework of modern biotechnology projects and therefore deserve careful consideration from the outset. Summary 1. From a legal standpoint, DNA is considered to be health information In Quebec, biological material and genetic data are not merely instruments of research. Under the law, they are defined as highly sensitive “health information”. The collection, use and transfer of this type of information is strictly regulated and requires explicit, informed consent. 2. Intellectual property does not confer all rights to the holder Just because a company develops a high-performance AI algorithm or an innovative biological model does not mean it can circumvent Quebec’s privacy laws. Bringing biotech products to market requires holding the necessary intellectual property rights AND complying with the legal framework governing the use of health data. 3. The pitfall of project drift (secondary uses) Consent obtained at the outset of a clinical research project usually does not extend to future uses, such as the integration of data into AI platforms. Organizations that fail to establish a solid contractual framework (e.g., transfer agreements, anonymization clauses) from the start may never be able to market their technology. Act respecting health and social services information, CQLR c R-22.1, ss. 1, 2, 5, 44 to 49 and 77. Act respecting the protection of personal information in the private sector, CQLR c P-39.1, ss. 4, 5, 8, 12 and 14. R. v. Dyment, 1988 CanLII 10 (SCC), [1988] 2 SCR 417 Marie Hirtle and Bartha Maria Knoppers, Le stockage des éléments du corps humain, les droits de propriété intellectuelle et les autres droits de propriété, Industrie Canada, 2014. Act respecting health and social services information, supra, note 1, s. 2. Id., ss. 5, 44 to 49 and 77. Act respecting the protection of personal information in the private sector, supra, note 2. Id., ss. 4, 5, 8, 12 and 14. Clausius, K., Kenny, E. & Crawford, M. J. (2023). BILL S-231: The Ethics of Familial and Genetic Genealogical Searching in Criminal Investigations. Canadian Journal of Bioethics / Revue canadienne de bioéthique, 6(3-4), 44–56. Act respecting health and social services information, supra, note 1, ss. 44 to 49; Act respecting the protection of personal information in the private sector, supra, note 2, ss. 12 and 14. Act respecting health and social services information, supra, note 1, ss. 48 and 49; Act respecting the protection of personal information in the private sector, supra, note 2, ss. 18.3 and 23. Act respecting health and social services information, supra, note 1, ss. 5 and 49; Act respecting the protection of personal information in the private sector, supra, note 2, ss. 12, 17 and 18.3.

Read more
March 18, 2026

Behind the Scenes of Sports, Data Never Takes a Break

The World Anti Doping Agency suffered a data breach in 2016—a vivid illustration that even the most prominent sporting institutions are not immune to cyber incidents. The authorities have now formalized what was previously just an observation: In a bulletin published in 2024, the Canadian Centre for Cyber Security warned that the entire sports ecosystem—spectators, athletes, organizations and government representatives—is the target of cyberattack campaigns. Malicious actors will attempt extortion through business email compromise, ransomware attacks, phishing, malicious websites and search engine poisoning, among others. Take heed, as when an incident occurs that is serious enough to require a report to the authorities, it is often too late to establish sound governance and engage in due diligence. The sporting competitions of today are producing massive amounts of data. The quantity is staggering, and the data itself almost Orwellian. Check the tables below to see for yourself. Data collected on athletes League Information collected NFL Performance data (statistics, position and movement metrics, speed, and passing, rushing and receiving yards) Medical and/or health data (examinations, injuries, concussion protocols) Substance screening data Data on disciplinary actions and investigations Professional and contractual data Travel, logistics and security data NHL Performance data Medical and/or health data (examinations, injuries, concussion protocols) Substance screening data Data on disciplinary actions and investigations Professional and contractual data Travel, logistics and security data MLB Performance data Medical and/or health data (examinations, injuries, concussion protocols) Substance screening data Data on disciplinary actions and investigations Professional and contractual data Travel, logistics and security data Collection of customer information online League Information collected NFL Information provided by individuals Identifiers: name, email, address, telephone number, date of birth; unique identifiers (username, password, SSN and other government identifiers if required, e.g. for awards) Demographic data and other protected categories: gender, race, ethnicity, sexual orientation Financial and commercial information: payment data, purchase history Real-time geolocation; precise geolocation Communication and marketing preferences Favorite team and inferences about preferences Audio, electronic and visual information (e.g., photos provided) Biometric data, if you opt for biometric authentication at the stadium; with consent and additional notice if required Information about your contacts (name, email) that you share; if authorized, access to your contacts, calendars and photos Search queries Content posted (comments, forums) Professional and employment information Education information Information that may be health-related (e.g., accessible seating) Correspondence, waivers, consents and other information sent Automatic collection Device and network identifiers and technical data: IP address, MAC address, advertising identifiers, device type, browser, OS Usage: page views, links clicked, browsing journeys, application usage data Tracking and emails: cookies, pixels, tags, interaction with emails (opened emails, clicks) Social media (if linked): data received according to your settings and the platform’s policy Logs and traffic: server logs, stadium Wi-Fi traffic Video and audio recordings: CCTV and pictures taken or video recorded during events NHL Information provided by individuals Identifiers and contact information (name, email, telephone number, address, date of birth) Commercial information (payments, purchases, services) Demographic data (language, age, gender, race, ethnicity, household composition and income) Preferences (favourite team, favourite players) Photos and/or videos Content, feedback (comments, surveys) Contact information of friends Application data (resume, references, checks permitted) Automatic collection Activity and interactions (content viewed, bids, purchases, time spent, cookies, tags), access methods (browser, OS, IP address, browsing history before and after) Device information and identifiers (type, unique identifiers, local content if allowed) Location (GPS, Bluetooth, Wi-Fi, cells) Inferences about preferences Commercial information about transactions (e.g., timestamps) Collection from third parties Member clubs (ticketing, login credential, usage logs) Fanatics, NHL Shop, NHL Auctions (name, email, items purchased; marketing engagement statistics) Other business partners, public sources, commercial sources (data brokers) Connected social media (according to the platform’s settings and policies) NHL teams* Contact information: name, email address, home address, gender, date of birth, telephone number (e.g., ticket purchase, ticket transfer, account creation, inquiries, contests, promotions) Demographic data and preferences (age group, race, gender; preferred events, preferred products, e.g., surveys) Health data related to accessibility needs Video surveillance in venues (security; sharing limited by law) Anonymous traffic analysis and device counting (cameras, technological devices; Wi-Fi); statistics that can be shared with partners Depersonalized web analytics (Google Analytics); opt-out option Online advertising and/or remarketing (Google, Facebook, LinkedIn, etc.) through cookies; opt-out mechanisms (platform settings; DAAC) Geolocation through applications if enabled Social media: profile data and authorized interactions Technical data (IP, browser, OS, resolution, location, language, origin, keywords, pages viewed, data entered, ads viewed), identifiers (IDFA, AAID), connection information (operator, ISP, Wi-Fi); ability to recognize a device) MLB Information provided by individuals Identifiers and contact information: full name, email address, home address, telephone numbers, date of birth Security and authentication: password Payments: payment details Demographic data: demographic characteristics Content and recordings: voice recordings, audiovisual recordings Preferences and interests: information about your interests and preferences Activity and event related data: information requested for an activity or event (e.g., emergency contact) Sensitive personal information: as defined by applicable laws (e.g., racial or ethnic origin; health information such as disabilities or allergies) Automatic collection Technical and usage data: IP addresses, device data, usage data Location and contacts: location data; contacts saved on your mobile device Collection from third parties Data from third parties and integrations: information provided by other companies if individuals connect their services * This data is collected about website users, people who visit venues, people who apply for jobs or participate in contests, people who submit drafts. How leagues are structured Regarding privacy and personal information, we must look at how sports leagues are organized to understand who does what. In most cases, sports leagues are non-profit organizations or corporations. An entire framework of rules is built around these structures, defining both how governance is done and what business model is used. First, there are the articles of association and by-laws, which dictate governance, team admissions, voting rights, and the powers of the commissioner or board of directors. There are also the sporting and competition regulations regarding eligibility, game schedules, transfers, drafts, salary caps and cost control mechanisms. The leagues also adopt integrity and security policies against doping, betting and manipulation, harassment and abuse, as well as commercial agreements covering broadcasting, sponsorships, ticketing and data leveraging, among others. There can also be collective agreements with players’ associations and formal dispute resolution mechanisms. In this environment, the league plays a central role. It generally has the power to adopt, interpret and amend its rules; admit teams; manage expansion and relocation projects and changes of control; as well as the power to impose sanctions such as fines, point deductions, suspensions or exclusions. It also centralizes strategic commercial rights, media rights, trademarks and data, and it implements revenue-sharing policies designed to maintain a competitive balance between teams. Personal information: the roles of each Teams In day-to-day relations with athletes and customers, teams are generally the main point of contact. They sign contracts with players, sell tickets, manage subscriptions and operate online stores and loyalty programs. In practice, teams are often the ones that collect personal information, that explain what the information is used for, that decide what information needs to be collected and that put in place security and incident management measures. Teams must therefore be able to clearly inform athletes and customers about the purposes for which personal information is collected, the means by which it is collected, the categories of information collected, who receives the information, and the rights that athletes and customers have. Teams must limit collection to what is necessary. They must ensure that information is accurate; they must obtain valid, manifest, free, informed and explicit consent for sensitive information such as health or biometric data; they must implement security measures adapted to risks; they must manage and report confidentiality incidents likely to cause serious harm; they must respond to requests for access and rectification; and they must stringently govern the sharing of information with service providers and mandataries. Athletes and customers often see the team as the true holder of their data. Leagues The role leagues play regarding personal information is more difficult to understand, as it varies depending on activities. When a league directly collects information from an individual, for example through an official application, a broadcasting platform or a transactional site for its own purposes, it must assume responsibilities comparable to those a team has. This is what MLB Advanced Media does, for example, defining itself as a “data controller” with respect to its customers’ data. But in many cases, the league acts behind the scenes. In some respects, it acts as a mandatary for the teams, negotiating and signing technology contracts, broadcasting agreements and other commercial agreements that will be used by the teams. In other respects, it acts as a service provider, offering centralized technology platforms, ticketing systems, data infrastructure and shared administrative services. Under Quebec law, these two roles—mandatary and service provider—are treated the same: The team can transmit to the league the information it needs to perform the mandate or service contract without having to ask for the consent of each person again, provided that a written agreement imposes clear measures to protect privacy, limits the use of data to the sole purposes of the mandate or service and governs data retention. The league must also promptly inform a team’s privacy officer of any privacy breach or attempted privacy breach and allow the officer to conduct checks. Also, teams and the league can always choose to base certain exchanges of information on the explicit consent of athletes or customers. However, such consent must be genuinely explicit, free, informed, given for specific purposes and presented separately when asked to be given in writing. Conclusion Although professional leagues are the ones in the spotlight, the same logic applies to amateur or non-professional sports organizations. In all cases, the relationship between the league, the team and the athlete or customer must be clearly governed from a privacy standpoint. Sports organizations should map the flow of personal information, harmonize the information messages they give to the those concerned, establish a standard agreement governing the sharing of information between teams and the league, provide simple mechanisms for access and rectification, and have key employees trained in privacy matters. Incorporating these points into articles of association, by-laws and team and league agreements will reduce risks and strengthen the confidence of athletes, parents, fans and business partners. Yet, a fundamental question still remains: Given that by law, data can only be collected for serious and legitimate reasons (necessity criterion), is the mass of information currently collected in the sports ecosystem really warranted? Sports organizations will have no choice but to delve into this strategic issue.

Read more
October 28, 2025

Export controls: implications in a world of knowledge sharing

Introduction When we hear the term “export controls,” we may think it only applies to weapons and other highly sensitive technologies, but that is not the case. There are a multitude of circumstances—some unexpected—to which it is important to know that export controls apply. This is especially true if you are involved in research or in the design and development of seemingly innocuous solutions that are not necessarily tangible objects. Today, technological knowledge is shared not only through conventional partnerships between businesses or universities, but also through data sharing or access to databases that feed large language models. Artificial intelligence is, in itself, a means of sharing knowledge. Feeding such algorithms with sensitive data, or data that can become sensitive when combined, carries a risk of violating the applicable legal framework. Here are some key concepts. Overview of the federal export control framework The Export and Import Permits Act In Canada, the Export and Import Permits Act (the “EIPA”) establishes the primary framework governing the export of controlled goods and technologies. The EIPA gives the Minister of Foreign Affairs the power to issue, to any resident of Canada who applies for one, a permit authorizing the export or transfer of a wide range of items included on the Export Control List (the “ECL”) or destined for a country listed on the Area Control List. In other words, the EIPA regulates, and at times prohibits, the trade of critical goods and technologies outside Canada. The Export Control List To get the full picture of the ECL, we need to refer to the Guide to Canada's Export Control Listas published by the Department with its successive amendments, the most recent of which date back to May 2025 (the “Guide”). In summary, the Guide includes military goods and technologies, strategic goods and dual-use (civilian and military) goods and technology that are controlled in accordance with Canada’s commitments made in multilateral regimes, such as the Wassenaar Arrangement on Export Controls for Conventional Arms and Dual-Use Goods and Technologies, bilateral agreements, and certain unilateral controls implemented by Canada as part of its defence policy. The Guide also includes forest products, agricultural and food products, apparel goods and vehicles. Other laws that affect exports Also to take into account are the sanctions that Canada imposes under laws that affect exports, such as: the United Nations Act the Special Economic Measures Act the Justice for Victims of Corrupt Foreign Officials Act These sanctions against specific countries, organizations or persons include a number of measures, including restricting or prohibiting trade, financial transactions or other economic activities with Canada, or the freezing of property located in Canada.1 Finally, in order for an individual (or an organization) to transfer controlled goods outside Canada, they must register with the Controlled Goods Program (the “CGP”) to obtain an export permit, unless exempt. Key concepts Did you know? Certain goods and technologies are referred to as “dual-use” goods and technologies. This means that even though they were initially designed for civilian use or appear harmless, they may be subject to export controls if they can be used for military purposes or to produce military items. A “technology” is broadly defined to include technical data, technical assistance and information necessary for the development, production or use of an item listed on the ECL. Also included in this notion, albeit indirectly, are the technologies referred to in any of the regulations associated with the laws listed above, which make certain countries subject to specific technology transfer restrictions. A “transfer” in relation to a technology, means to dispose of it (e.g. sell it) or disclose its content in any manner from a place in Canada to a place outside Canada. This definition stems from legislative amendments to the EIPA, which expanded the scope of the law to include the mere transfer of intangible technologies by various means, thereby broadening the circumstances to which permits apply as regards transfers.2 Regarding trade relations with the United States, Canadian exporters may face additional restrictions and considerable challenges, particularly in situations where their employees or other stakeholders involved are foreign nationals.The International Traffic in Arms Regulations (“ITAR”) and the Export Administration Regulations(“EAR”) are two key sets of rules that govern exports from the United States.3 They protect both similar and distinct interests. While the ITAR aim to protect defence articles and defence services (including weapons and information), the EAR govern dual-use items.4 Both prevent exports5 in a broad sense, i.e., up to and including the transfer of information to so-called “foreign” persons, except with the permission of the authorities. It is thus quite possible that Canadian exporters will be required to comply with these American regulations, which, in addition to targeting territories, target the national origin of individuals. This is diametrically opposed to Canada’s export regime, which rather centres on prohibiting trade with a country or anyone located there. In this regard, note that Quebec’s Charter of Human Rights and Freedoms considers national origin to be a ground for discrimination. 6 A Quebec business can thus find itself struggling to balance its contractual obligations under a contract with an American company with the requirements of the Quebec Charter. Artificial intelligence: novel challenges The development of large language models in the field of artificial intelligence represents a new challenge from an export control standpoint, and a significant one at that. For example, if a large language model is trained using restricted data, a state subject to the aforementioned sanctions might attempt to use the large language model to indirectly obtain information to which it would not otherwise have had direct access. As a result, training a large language model on plans, technical specifications or textual descriptions of technologies covered by transfer restrictions (which can include knowledge transfers) can create a risk of non-compliance with the law. The same applies to accessing such data for retrieval-augmented generation, a widely used technique to expand and improve large language model responses. To limit the risk during research and development, a company that trains a large language models on such data or allows access to such data for retrieval-augmented generation will need to consider where the data will be hosted and processed. Similarly, once the artificial intelligence application is developed, it will be important to restrict access to it in a manner consistent with the law, both in terms of locating the servers on which the large language model will be installed and in terms of user access. Sanctions Any person or organization that contravenes any provision of the EIPA or its regulations commits an offence punishable by fine and/or imprisonment, as applicable. Also, failure to register with the CGPmay constitute an offence under federal laws that can lead to prosecution and substantial sanctions against the offender(s).7 Conclusion Canada’s export controls are quite complex, not only in how they are structured, but also in how they must be implemented. With the changing geopolitical and commercial landscape, it is advisable to periodically read the resources made available by the relevant authorities and put in place appropriate policies and measures, or to seek professional advice in this regard. Government of Canada, “Types of sanctions” (date modified: 2024-09-10): Types of sanctions Martha L. Harrison & Tonya Hughes, “Understanding Exports: A Primer on Canada’s Export Control Regime” (2010) 8(2) Canadian International Lawyer, 97 The ITAR and EAR are included in the Code of Federal Regulations (“CFR”). Austin D. Michel, “Hiring in the Export-Control Context: A Framework to Explain How Some Institutions of High Education Are Discriminating against Job Applicants” (2021) 106:4 Iowa L Review, 1993 The ITAR and EAR also provide for restrictions on re-exportation. See Maroine Bendaoud, “Quand la sécurité nationale américaine fait fléchir le principe de non-discrimination en droit canadien : le cas de l'International Traffic in Arms Regulations (ITAR)” (2013) Les cahiers de droit, 54 (2–3), 549 Government of Canada, “Guideline on Controlled Goods Program registration” (date modified: 2025-05-08): Guideline on Controlled Goods Program registration – Canada.ca

Read more
May 23, 2025

Provincial Budget 2025: New Refundable Tax Credit for Research, Innovation and Commercialization (CRIC)

As part of the Quebec budget for 2025, the provincial government has announced a host of new tax measures and changes to existing tax measures. This series of bulletins will provide an overview of three of these measures which introduce significant tax changes and will have a considerable impact on many Quebec businesses: the introduction of the CRIC, changes to the tax credit for the development of e-business (TCEB) and changes to the public utility tax (PUT). Research and development tax credits, such as the R&D tax credit for salaries and wages, the university research tax credit and the pre-competitive research tax credit, all have a very important place in Quebec’s tax and economic systems. They were designed to provide substantial tax support for businesses investing in research and development (R&D), while reducing the financial risks inherent to such activities. The new CRIC simplifies and centralizes these tax measures by grouping them under a single tax credit, making application for Quebec businesses more consistent and efficient. This new credit’s basic rate will be 20%, with an increased rate of 30% applicable to the first million dollars of eligible expenses. This structure is designed to be internationally competitive and help Quebec businesses maintain a significant tax advantage over their counterparts in other jurisdictions. To benefit from the credit, a business must carry out R&D or commercialization activities in Quebec and incur eligible expenses in the course of these activities. Eligible expenses include salaries directly linked to research, payments to subcontractors and research organizations and certain capital expenditures, save for those made to acquire real estate property such as land, buildings and rights of use over buildings. The real estate exclusion is intended to ensure that tax support is spent on technological innovation rather than real estate investments. The credit takes effect for all tax years ending after March 25, 2025. The tax credits for scientific research and experimental development, university research or public research centres, private partnership pre-competitive research, fees and dues paid to a research consortium, technological adaptation services and industrial design are all abolished, as they are now included in the new CRIC.

Read more